From: Analysis and design of randomised clinical trials involving competing risks endpoints
Variables | O | E | Unadjusted HR (95% CI) | p-value |
---|---|---|---|---|
M : Distant metastasis | Â | Â | Â | Â |
   RT | 38 | 26.54 | 0.43 (0.25 - 0.72) | 0.002 |
   CRT | 18 | 29.46 | 1.00 |  |
R : Loco-regional recurrence | Â | Â | Â | Â |
   RT | 10 | 9.19 | 0.84 (0.34 - 2.07) | 0.711 |
   CRT | 9 | 9.81 | 1.00 |  |